Pharmaceutical Benefits Scheme (PBS) | Home

Treatment dose and frequency. Reason for stopping. Please confirm the patient has moderate to severe atopic dermatitis, (defined as EASI score ≥16): Baseline EASI score. Baseline DLQI score. Date Assessed. Yes No Please confirm ≥10% body surface area of atopic dermatitis … ................
................